Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 71 clinical trials
Migraine Prophylaxis With Clopidogrel Trial

evaluate the prophylactic effectiveness of clopidogrel for migraineurs with RLS.

headache
migraine prophylaxis
  • 0 views
  • 01 Sep, 2021
  • 1 location
CES1 Crossover Trial of Clopidogrel and Ticagrelor

aggregometry, in healthy participants treated with clopidogrel and ticagrelor. We hypothesize that genetic variation in CES1 will significantly impact on-clopidogrel platelet aggregation while having a minimal

Accepts healthy volunteers
genetic variation
platelet aggregation
ticagrelor
antiplatelet therapy
  • 68 views
  • 24 Mar, 2022
  • 1 location
Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm

Low clopidogrel response has been reported in about 5-44% of the total population, which is associated with an increase in thromboembolism. Recently prasugrel drug widely accepted as a

Accepts healthy volunteers
aspirin
embolization procedure
  • 0 views
  • 04 Oct, 2022
  • 1 location
PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers

This clinical study will adopt an open-label, randomized, multiple-dose, two-crossover design to explore the pharmacokinetic and pharmacodynamic profiles of Vicagrel Capsules and Clopidogrel

clopidogrel
Accepts healthy volunteers
body mass index
  • 0 views
  • 04 Oct, 2022
  • 3 locations
Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI (SWAP-AC-2)

Clopidogrel is the P2Y12 inhibitor of choice in PCI patients requiring OAC. However, concerns have been raised based on the notion that a considerable number of patients may have inadequate

clopidogrel
dapt
aspirin
ticagrelor
  • 0 views
  • 04 Oct, 2022
  • 1 location
Phase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud Phenomenon (PSSIT)

Systemic sclerosis (SSc) is a severe autoimmune disease associating dysimmunity, vasculopathy and fibrosis. No curative treatment is available. Pre-clinical abnormalities can be found such as specific autoantibodies. The association of Raynaud phenomenon and SSc-specific anti-nuclear antibodies is the hallmark of pre-scleroderma subjects, among who around 47% declare a complete disease …

fibrosis
raynaud's syndrome
autoimmune disease
raynaud's phenomenon
scleroderma
  • 0 views
  • 28 Oct, 2022
  • 1 location
A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention (APLABE-PCI)

64 patients receiving aspirin and clopidogrel who are at > 8 but ≤ 40 weeks after percutaneous coronary intervention.

percutaneous coronary intervention
clot
revascularisation
plato
coronary revascularization
  • 23 views
  • 23 Oct, 2022
  • 1 location
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke (TREND)

Currently, dual antiplatelet therapy with aspirin and clopidogrel (with loading doses) is widely used for patients with acute ischemic stroke. However, immediate, potent and reversible

clopidogrel
aspirin
ischemic stroke
  • 0 views
  • 04 Oct, 2022
  • 7 locations
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE (APPENDAGE)

valvular atrial fibrillation (AF). The primary objective of the study is to evaluate the efficacy of Aspirin versus Aspirin + Clopidogrel after LAAC by comparing the occurrence of ischemic lesions on

  • 0 views
  • 28 Oct, 2022
  • 1 location
Effects of Edoxaban on Platelet Aggregation

acetylsalicylic acid (ASA). Subjects initially will receive in the following sequence: ASA 100 mg once daily (QD) plus edoxaban 60 mg QD, clopidogrel 75 mg QD alone, clopidogrel 75 mg QD plus edoxaban 60 mg QD

antiplatelet agents
angiography
aspirin
coronary angioplasty
coronary artery bypass graft
  • 0 views
  • 22 Nov, 2021
  • 1 location